This inventor holds 1 USPTO granted patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Yong Lee Bong - Innovator in Pharmaceutical Chemistry
Introduction
Yong Lee Bong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.
Latest Patents
Yong Lee Bong holds a patent for a heterocyclic compound, which is represented by a specific chemical formula. This invention is aimed at the prevention and treatment of diseases caused by abnormalities in prolyl-tRNA synthetase (PRS) activity. The patent also includes a method for preparing the compound and a pharmaceutical composition that incorporates it.
Career Highlights
Yong Lee Bong is currently associated with Daewoong Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work focuses on innovative solutions that enhance therapeutic options for various diseases.
Collaborations
He collaborates with notable colleagues, including Joon Seok Park and Youn Jung Yoon, who contribute to his research and development efforts.
Conclusion
Yong Lee Bong's innovative work in pharmaceutical chemistry exemplifies the impact of research and development in healthcare. His contributions continue to pave the way for advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile